Rankings
▼
Calendar
JANX Q1 2023 Earnings — Janux Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
JANX
Janux Therapeutics, Inc.
$852M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
+28.9% YoY
Gross Profit
-$14M
-674.7% margin
Operating Income
-$20M
-990.3% margin
Net Income
-$17M
-852.5% margin
EPS (Diluted)
$-0.42
QoQ Revenue Growth
-28.0%
Cash Flow
Operating Cash Flow
-$14M
Free Cash Flow
-$14M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$353M
Total Liabilities
$42M
Stockholders' Equity
$311M
Cash & Equivalents
$30M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$2M
+28.9%
Gross Profit
-$14M
-$9M
-60.8%
Operating Income
-$20M
-$14M
-49.8%
Net Income
-$17M
-$13M
-30.2%
← FY 2023
All Quarters
Q2 2023 →